Entering text into the input field will update the search result below
Search for Symbols, analysts, keywords

Iovance Biotherapeutics (IOVA) Investor Presentation - Slideshow

SA Transcripts profile picture
SA Transcripts
140.66K Followers

The following slide deck was published by Iovance Biotherapeutics, Inc. in conjunction with this event.

View as PDF
Tumor Infiltrating Lymphocyte Cell
151

This article was written by

SA Transcripts profile picture
SA Transcripts
140.66K Followers
Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team

Recommended For You

Comments (3)

m
mdflin
08 Apr. 2021
Comments (6)
Still don’t understand why they haven’t resolved the FDA assay issue since it’s been 6 months? Don’t blame Covid please.
mookdoc profile picture
mookdoc
08 Apr. 2021
Premium
Comments (2.99K)
@mdflin I have explained it before...inconsistencies in MFG? FDA gonna have field day with that...everybody better check your calendar because this will be very lengthy If ever resolved imo?
C
CashRulla
09 Apr. 2021
Premium
Comments (53)
@mookdoc this treatment is curing previously incurable cancer. The FDA may slow this, but cancer patients and their families are going to put a lot of pressure on them to figure out a solution here. I find the IOVA data astounding and I’m buying more.
Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.